drugset / Trial / NCT04107441
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
Non-randomizedSequentialOpen-labelTreatment
Summary
The main purpose of the study is to see how safe the study drug AX-8 is and how well it is tolerated when administered at different dose levels in healthy participants. The study will also investigate pharmacokinetics (PK), i.e how the study drug is taken up, metabolized (broken down) and eliminated.
Timeline
- Start
- 2019-09-09
- Primary completion
- 2020-02-25
- Completion
- 2020-03-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AX-8 | Unknown | 5 mg | Oral |
| Subject | AX-8 | Unknown | 10 mg | Oral |
| Subject | AX-8 | Unknown | 20 mg | Oral |
| Subject | AX-8 | Unknown | 40 mg | Oral |
Indications
No indication recorded.